We asked the patient and her family about the detailed medication history, known she had taking herb for weakness and lower limb pain, though the specific drug was unclear
1 09:30 10:00 12:0060 13:00 15:3030 16:00 18:30 3 ChloeGUCCIBURBERRYJIL SANDER13 20JIL SANDER 46040 8 13 OK
TMAO also increases platelet activity via Ca 2+ stimulation and contributes to atherosclerosis, further promoting the development of cardiovascular disease (CVD) (Zhu et al., 2016)
Upon activation, they can enhance the proliferation and activation of engineered T cells by promoting T cell receptor (TCR) and cytokine-driven JAK-STAT signaling ( ex vivo , and then reinfused into the patient ( Kymriah, a CD19-specific CAR-T product, was the first to be approved on August 31, 2017, for treating patients with refractory or relapsed B-cell precursor acute lymphoblastic leukemia (B-ALL) ( Yescarta, a second CD19-specific CAR-T product, was approved on October 18, 2017, for adult patients with relapsed/refractory large B-cell lymphoma (R/R LBCL), including diffuse large B-cell lymphoma (DLBCL), primary mediastinal B-cell lymphoma (PMBCL), high-grade B-cell lymphoma (HGBCL), and transformed follicular lymphoma (TFL), after two or more lines of systemic therapy ( Tecartus, a third anti-CD19 CAR-T product, was approved for the treatment of relapsed/refractory mantle cell lymphoma (R/R MCL) patients on July 24, 2020 ( Breyanzi, another CD19-specific CAR-T product, was approved on February 5, 2021
